Implementing Residential Integrated Treatment for Co-occurring Disorders
- 期刊名称Journal of Dual Diagnosis
- 作者McKee, Shari A.; Harris, Grant T.; Cormier, Catherine A.
- 卷第9卷
- 期第3期
- 印刷ISSN1550-4263
- 电子ISSN1550-4271
- 文件大小223.79KB
- 发表时间2013-08
- DOI10.1080/15504263.2013.807073
- 页码249-259
Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearerXing, Mingzhao · BMC Medicine · 2016
ras Mutations Are Associated With Aggressive Tumor Phenotypes and Poor Prognosis in Thyroid CancerGarcia-Rostan, G. · Journal of Clinical Oncology · 2003
Ras mutations are uncommon in sporadic thyroid cancer in children and young adultsFenton, C.; Anderson, J.; Lukes, Y.; Dinauer, C. A. Welch; Tuttle, R. M.; Francis, G. L. · Journal of Endocrinological Investigation · 1999
TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer casesCacciato Insilla, Andrea; Proietti, Agnese; Borrelli, Nicla; Macerola, Elisabetta; Niccoli, Cristina; Vitti, Paolo; Miccoli, Paolo; Basolo, Fulvio · Oncology Letters · 2017
Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid CancerL. Santarpia; A. K. El-naggar; G. J. Cote; J. N. Myers; S. I. Sherman · 2007
Low Prevalence of TERT Promoter, BRAF and RAS Mutations in Papillary Thyroid Cancer in the Greek PopulationArgyropoulou, Marilena; Veskoukis, Aristidis S.; Karanatsiou, Pagona-Maria; Manolakelli, Aikaterini; Kostoglou-Athanassiou, Ifigenia; Vilaras, George; Karameris, Andreas; Liadaki, Kalliopi · Pathology & Oncology Research · 2018
Clinical significance of RET and RAS mutations in sporadic medullary thyroid cancer-a meta-analysisVuong, Huy Gia; Odate, Toru; Ngo, Hanh T.t.; Pham, Thong Quang; Tran, Thao T.k.; Mochizuki, Kunio; Nakazawa, Tadao; Katoh, Ryohei; Kondo, Tetsuo · Endocrine-Related Cancer · 2018
Therapy for Metastatic Colorectal CancerGoldberg, R. M. · The Oncologist · 2006
Overcoming Resistance to Antiangiogenic TherapiesTejpar, S.; Prenen, H.; Mazzone, M. · The Oncologist · 2012
Nodular Lymphocyte Predominant Hodgkin LymphomaLee, A. I.; LaCasce, A. S. · The Oncologist · 2009
Managing Paraneoplastic Neurological Disordersde Beukelaar, J. W. · The Oncologist · 2006
Neuroendocrine Tumors of the PancreasEhehalt, F.; Saeger, H. D.; Schmidt, C. M.; Grutzmann, R. · The Oncologist · 2009
Clinical Mimics of LymphomaBrown, J. R. · The Oncologist · 2004
Adenoviral Gene TherapyVorburger, S. A. · The Oncologist · 2002
Management of Bone MetastasesColeman, R. E. · The Oncologist · 2000